Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01820364
Show Display Options
Rank Status Study
1 Completed LGX818 in Combination With Agents (MEK162; BKM120; LEE011; BGJ398; INC280) in Advanced BRAF Melanoma
Condition: Melanoma
Intervention: Drug: LGX818

Study has passed its completion date and status has not been verified in more than two years.